Larvol Delta - BioThera-Solutions-Initiates-Phase-I-Clinical-Trial-for-BAT2206-a-Proposed-Biosimilar-of-Stelara-Ustekinumab

BAT2206 (ustekinumab biosimilar) - Bio-Thera Solutions

https://www.businesswire.com/news/home/20200903005319/en/Bio-Thera-Solutions-Initiates-Phase-Clinical-Trial-BAT2206

Sep 3, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next